Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Ginkgo Biloba

Q: Is Ginkgo biloba effective for memory improvement?

Evidence suggests modest cognitive benefits in individuals with mild cognitive impairment and dementia, but not in healthy individuals.

Q: Is it safe long-term?

Long-term use appears safe, with no major adverse effects reported in trials lasting several years.

Q: Can it be combined with other cognitive enhancers?

It is often studied with donepezil; the combination may improve outcomes without increasing adverse effects.

Q: Does it cause bleeding?

A theoretical risk exists, but clinical evidence of increased bleeding is minimal; caution is advised with anticoagulants.

Also known as: Ginkgo biloba L., Maidenhair tree, Ginkgo, GBE, EGb 761, Ginkgo biloba

Overview

Ginkgo biloba is a tree native to China, and its leaves are used to produce standardized extracts for dietary supplements. These extracts contain flavonoids and terpenoids, known for their antioxidant and neuroprotective properties. Ginkgo biloba is primarily used to enhance cognitive function, treat dementia, and manage neuropsychiatric conditions. Standardized extracts like EGb 761 have been extensively researched through numerous randomized controlled trials (RCTs) and meta-analyses. While the evidence quality varies, several high-quality systematic reviews support its benefits. Ginkgo biloba's mechanisms include antioxidant effects, neurotransmitter modulation, anti-inflammatory actions, and vasoregulation, contributing to its therapeutic effects.

Benefits

Ginkgo biloba extract has demonstrated benefits in cognitive function and dementia. Meta-analyses indicate improvements in Mini-Mental State Examination (MMSE) scores, Activity of Daily Living scores, and other cognitive scales in patients with dementia and mild cognitive impairment. One meta-analysis of 18 RCTs (n=1,642) showed significant improvements compared to control groups (p < 0.00001). Additionally, systematic reviews suggest improvements in cognitive function and reduced positive symptoms in schizophrenia patients. Ginkgo biloba extract may also benefit individuals with idiopathic pulmonary fibrosis (IPF), with meta-analyses showing significant reductions in serum markers associated with pulmonary fibrosis (hyaluronic acid, laminin) (p < 0.001), suggesting potential anti-fibrotic effects. Meta-analyses also indicate a favorable safety profile, with no significant increase in adverse effects compared to placebo or standard treatments.

How it works

Ginkgo biloba extract's mechanism of action involves several pathways. Its flavonoids and terpenoids act as antioxidants, scavenging free radicals and reducing oxidative stress. The extract modulates neurotransmitter systems, enhancing cholinergic transmission, which may improve cognitive function. It also exhibits anti-inflammatory and vasoregulatory effects, improving cerebral blood flow. Ginkgo biloba may inhibit platelet-activating factor, contributing to neuroprotection. Standardized extracts like EGb 761 ensure consistent levels of active compounds, enhancing bioavailability and efficacy.

Side effects

Ginkgo biloba is generally well-tolerated. Common side effects (occurring in >5% of users) include mild gastrointestinal symptoms and headaches. Uncommon side effects (1-5%) may include allergic skin reactions. Rare side effects (<1%) involve potential bleeding risk due to platelet-activating factor inhibition, though the clinical significance is low. Caution is advised when using Ginkgo biloba with anticoagulants and antiplatelet drugs due to potential drug interactions. It is contraindicated in patients with bleeding disorders or those on blood thinners. The safety of Ginkgo biloba during pregnancy and breastfeeding is not well established, warranting caution in these populations.

Dosage

The typical minimum effective dose of Ginkgo biloba is 120 mg/day of a standardized extract, such as EGb 761. The optimal dosage ranges from 120 to 240 mg/day, divided into two doses. A maximum safe dose of up to 240 mg/day is generally considered safe. It is recommended to take Ginkgo biloba twice daily with meals to improve absorption. Standardized extracts are preferred for consistent efficacy. Fatty meals may enhance bioavailability. No specific cofactors are required for Ginkgo biloba supplementation.

FAQs

Is Ginkgo biloba effective for memory improvement?

Evidence suggests modest cognitive benefits in individuals with mild cognitive impairment and dementia, but not in healthy individuals.

Is it safe long-term?

Long-term use appears safe, with no major adverse effects reported in trials lasting several years.

Can it be combined with other cognitive enhancers?

It is often studied with donepezil; the combination may improve outcomes without increasing adverse effects.

Does it cause bleeding?

A theoretical risk exists, but clinical evidence of increased bleeding is minimal; caution is advised with anticoagulants.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC3679686/ – This systematic review and meta-analysis included multiple RCTs on schizophrenia and dementia patients. It found that Ginkgo biloba reduced positive symptoms in schizophrenia and improved cognition and daily living activities in dementia, suggesting potential benefits for these conditions.
https://pubmed.ncbi.nlm.nih.gov/25114079/ – This systematic review and meta-analysis analyzed Ginkgo biloba for cognitive impairment and dementia, confirming its efficacy in improving cognitive scores and daily function with low adverse effects. The review highlighted variability in study quality but consistent positive findings, supporting its use in cognitive decline.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1524505/full – This meta-analysis evaluated Ginkgo biloba extract's effects on fibrosis biomarkers in idiopathic pulmonary fibrosis (IPF), showing significant reductions in hyaluronic acid and laminin levels (p < 0.001). These findings suggest that Ginkgo biloba has anti-fibrotic potential and may be beneficial in managing IPF.
https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2023.1124710/full – This meta-analysis of 18 RCTs (n=1,642) found significant improvements in MMSE, ADL, and other cognitive scales with Ginkgo biloba combined with donepezil compared to donepezil alone. While the methodological quality was variable with some risk of bias, the results were statistically robust, indicating a potential synergistic effect.